Antenatal corticosteroid: brain, behaviour, and epigenetics
Please join us …
When: Tuesday, April 2, 2019, 12–1 p.m.
Where: ICES, G-Wing, Conference Centre (Sunnybrook Health Sciences Centre)
Who: Elizabeth Asztalos MD MSc FRCPC; Associate Professor, Department of Paediatrics, University of Toronto; Staff Neonatologist, Department of Newborn & Developmental Paediatrics; Director of Neonatal Research, Women and Babies Program, Sunnybrook Health Sciences Centre.
Topic: Antenatal corticosteroid: brain, behaviour, and epigenetics
review current status of use of antenatal corticosteroids (ACS): benefits to the preterm infant <28 completed weeks gestation
understand expanded use of ACS: perceived benefits to the later preterm infant
review the literature evaluating the effect of ACS on fetuses exposed to ACS but then born at term
potential study to evaluate the effects of ACS on the exposed fetus born at term